Get started Log in

QBIO — Q BioMed Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
$0.00m
Enterprise Value
$9.25m
Revenue
$0.28m

Brief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
14/04/2023 15:16
Brief: Q Biomed Provides Shareholder Update
11/10/2022 13:36
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
16/03/2022 12:40
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
22/09/2021 14:58
Brief: Q Biomed To Scale Up Production Of Uttroside-B
22/07/2020 14:09
Brief: Q BioMed Inc Says ITG Is Now Cleared To Manufacture Co's FDA Approved Non-Opioid Cancer Bone Pain Drug Strontium-89 Chloride USP
20/11/2019 13:59
Brief: Q Biomed Partners With Jubilant Radiopharma to Distribute Cancer Drug
03/10/2019 14:07
Brief: Q Biomed Announces Legal Settlement And Acquisition Of FDA Approved Non-Opioid Metastatic Cancer Pain Drug
02/10/2019 16:45
Brief: Q BioMed Announces Updates On Commercialization Of Non-Opioid Metastatic Cancer Pain Drug
11/07/2019 13:54
Brief: Q BioMed Adds Clinical Psychologist at Yale's Child Study Center
16/01/2019 13:37
Brief: Q Biomed Acquires Cancer Pain Drug Metastron From GE Healthcare
28/11/2018 13:07
Brief: Q Biomed Inc. Announces Dr. Rajendra Apte Joins Advisory Board
17/09/2018 22:11
Brief: Q BioMed Provides Update On Mannin Research Tie2 Technology Platform Development
06/06/2018 13:49
Brief: Q Biomed Adds Boston University's Dr. Tager-Flusberg To Advisory Committee
28/11/2017 13:03